PATRICIA OBENG: Open Payments
NPI 1750937751 · MANASSAS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$497 in 9 payments from 6 companies in 2025. Trend: 2023 $71 · 2024 $711 · 2025 $497
Food & beverage: $497
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $170 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $124 |
| Braeburn Inc. | 1 | $109 |
| Vanda Pharmaceuticals Inc. | 2 | $58 |
| Alkermes, Inc. | 1 | $18 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $18 |
Products named: REXULTI, CAPLYTA, BRIXADI, FANAPT, VIVITROL, ABILIFY MAINTENA.
Industry payments across VA — which companies pay providers there.
